Mild form of Guillain-Barré syndrome in a patient with primary Epstein-Barr virus infection

Kim, Se Yong; Choe, Kang Won; Park, Sehhoon; Yoon, Doran; Ock, Chan Young; Hong, Seung Wook; Heo, Jung Yeon

doi:10.3904/kjim.2015.033

Cited by 10 publications

(9 citation statements)

References 4 publications

(3 reference statements)

Supporting

Mentioning

Contrasting

Order By: Relevance

“…GBS comprises an acute inflammatory demyelinating polyneuropathy of global incidence, in which about two-thirds of cases occur after bacterial (e.g. Campylobacter jejuni) (Heikema et al, 2015) or viral infection (Oehler et al, 2015), such as by Dengue- (Simon et al, 2016), West Nile- (Leis and Stokic, 2012), Influenza- (Choi and Yeon, 2016), Cytomegalo- (Steger et al, 2012), Human Immunodeficiency- (Girgin et al, 2014), Epstein-Barr (Phillips, 1973;Kim et al, 2016) and Zika viruses (Rozé et al, 2017).…”

Section: Atypicalmentioning

confidence: 99%

A scoping review of Chikungunya virus infection: epidemiology, clinical characteristics, viral co-circulation complications, and control

et al. 2018

View full text Add to dashboard Cite

Chikungunya fever is a mosquito-borne viral illness characterized by a sudden onset of fever associated with joint pains. It was first described in the 1950s during a Chikungunya virus (CHIKV) outbreak in southern Tanzania and has since (re-) emerged and spread to several other geographical areas, reaching large populations and causing massive epidemics. In recent years, CHIKV has gained considerable attention due to its quick spread to the Caribbean and then in the Americas, with many cases reported between 2014 and 2017. CHIKV has further garnered attention due to the clinical diagnostic difficulties when Zika (ZIKV) and dengue (DENV) viruses are simultaneously present. In this review, topical CHIKV-related issues, such as epidemiology and transmission, are examined. The different manifestations of infection (acute, chronic and atypical) are described and a particular focus is placed upon the diagnostic handling in the case of ZIKV and DENV co-circulating. Natural and synthetic compounds under evaluation for treatment of chikungunya disease, including drugs already licensed for other purposes, are also discussed. Finally, previous and current vaccine strategies, as well as the control of the CHIKV transmission through an integrated vector management, are reviewed in some detail.

show abstract

Section: Atypicalmentioning

confidence: 99%

A scoping review of Chikungunya virus infection: epidemiology, clinical characteristics, viral co-circulation complications, and control

et al. 2018

View full text Add to dashboard Cite

show abstract

“…It also could be that these entities happened simultaneously. EBV has been associated with AIDP in 5% to 28% of cases [ 6 ]. EMG is the most specific and sensitive tests for the diagnosis of AIDP [ 7 ].…”

Section: Discussionmentioning

confidence: 99%

Dermatomyositis-Induced Rhabdomyolysis With Features of Necrotizing Myopathy and Acute Inflammatory Demyelinating Polyneuropathy in an Epstein-Barr Virus Infected Patient

Haikal

Govil

Anis

et al. 2020

Cureus

View full text Add to dashboard Cite

“…The association of various microorganisms with Guillain-Barrésyndrome has been reported such as Campylobacter jejuni (C. jejuni), Mycoplasma pneumoniae, Haemophilus influenza, Cytomegalovirus (CMV), Epstein-Barr virus (EBV), influenza A, varicella-zoster, hepatitis (A, B and E), Zika and Chikungunya viruses (78)(79)(80)(81)(82)(83)(84)(85)(86)(87)(88)(89)(90)(91). C. jejuni has been identified as the most common pathogen causing this disorder (91,92).…”

Section: Possible Mechanisms Of Guillain-barreś Yndrome Involving Virus and Bacteriamentioning

confidence: 99%

SARS-CoV-2 Infection and Guillain-Barré Syndrome: A Review on Potential Pathogenic Mechanisms

et al. 2021

View full text Add to dashboard Cite

Since December 2019, the world has been facing an outbreak of a new disease called coronavirus disease 2019 (COVID-19). The COVID-19 pandemic is caused by a novel beta-coronavirus named severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The SARS-CoV-2 infection mainly affects the respiratory system. Recently, there have been some reports of extra-respiratory symptoms such as neurological manifestations in COVID-19. According to the increasing reports of Guillain-Barré syndrome following COVID-19, we mainly focused on SARS-CoV-2 infection and Guillain-Barré syndrome in this review. We tried to explain the possibility of a relationship between SARS-CoV-2 infection and Guillain-Barré syndrome and potential pathogenic mechanisms based on current and past knowledge.

show abstract

Mild form of Guillain-Barré syndrome in a patient with primary Epstein-Barr virus infection

Cited by 10 publications

References 4 publications

A scoping review of Chikungunya virus infection: epidemiology, clinical characteristics, viral co-circulation complications, and control

A scoping review of Chikungunya virus infection: epidemiology, clinical characteristics, viral co-circulation complications, and control

Dermatomyositis-Induced Rhabdomyolysis With Features of Necrotizing Myopathy and Acute Inflammatory Demyelinating Polyneuropathy in an Epstein-Barr Virus Infected Patient

SARS-CoV-2 Infection and Guillain-Barré Syndrome: A Review on Potential Pathogenic Mechanisms

Contact Info

Product

Resources

About